Targeting hedgehog‐GLI‐2 pathway in osteosarcoma
Open Access
- 11 September 2012
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 31 (3) , 502-509
Abstract
Osteosarcoma is the most common primary malignant tumor of bone. Patients with localized osteosarcoma are routinely treated with chemotherapy and surgery. However, many of these patients eventually relapse after these treatments. In such cases, there are limited treatment options for these patients and most will eventually die with metastatic disease. Therefore, it is imperative to identify better therapeutic strategies. Hedgehog‐GLI is responsible for the development of vertebrate embryonic and tumorigenesis. Specifically, the transcription factor, GLI‐2, plays a key role in development of normal prostate. Aberrant activation of GLI‐2 is correlated with various malignancies. We observe that GLI‐2 is highly expressed in osteosarcoma cell lines, and this correlates with poor clinical outcomes in patients. Knockdown of GLI‐2 by siRNA decreases osteosarcoma cell proliferation and viability, which eventually induces cell death as revealed in both in 2D and 3D cultures. In addition, we notice that administration of GLI‐2 siRNA can increase the sensitivity of osteosarcoma cells to chemotherapeutic drugs. These findings suggest GLI‐2 is required for osteosarcoma cell proliferation and survival. GLI‐2 may be exploited as a therapeutic target for the treatment of osteosarcoma patients. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31: 502–509, 2013Keywords
Funding Information
- Gattegno and Wechsler funds
- Kenneth Stanton Fund
- Jennifer Hunter Yates Foundation
- Sarcoma Foundation of America
This publication has 22 references indexed in Scilit:
- Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancerLung Cancer, 2012
- Role of GLI2 in the growth of human osteosarcomaThe Journal of Pathology, 2011
- Hedgehog signaling maintains chemoresistance in myeloid leukemic cellsOncogene, 2010
- Blockage of Stat3 With CDDO-Me Inhibits Tumor Cell Growth in ChordomaSpine, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated‐Stat3 correlates with poor prognosisJournal of Orthopaedic Research, 2010
- Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell linesMolecular Cancer Therapeutics, 2009
- GLI2 Knockdown Using an Antisense Oligonucleotide Induces Apoptosis and Chemosensitizes Cells to Paclitaxel in Androgen-Independent Prostate CancerClinical Cancer Research, 2008
- The Gli code: an information nexus regulating cell fate, stemness and cancerTrends in Cell Biology, 2007
- Targeting the Hedgehog pathway in cancerNature Reviews Drug Discovery, 2006